Anteris Technologies Global (NASDAQ:AVR – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Anteris Technologies Global to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, dividends, earnings and risk.
Earnings and Valuation
This table compares Anteris Technologies Global and its peers top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Anteris Technologies Global | $2.24 million | -$94.14 million | -3.07 |
| Anteris Technologies Global Competitors | $1.89 billion | $135.83 million | 12.24 |
Anteris Technologies Global’s peers have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of recent ratings and price targets for Anteris Technologies Global and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Anteris Technologies Global | 1 | 1 | 3 | 0 | 2.40 |
| Anteris Technologies Global Competitors | 4281 | 10557 | 18338 | 829 | 2.46 |
Anteris Technologies Global presently has a consensus target price of $14.00, indicating a potential upside of 133.72%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.62%. Given Anteris Technologies Global’s higher possible upside, equities analysts plainly believe Anteris Technologies Global is more favorable than its peers.
Volatility & Risk
Anteris Technologies Global has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Anteris Technologies Global’s peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.
Profitability
This table compares Anteris Technologies Global and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Anteris Technologies Global | -4,619.27% | -77.69% | -67.99% |
| Anteris Technologies Global Competitors | -304.51% | -178.77% | -22.17% |
Summary
Anteris Technologies Global peers beat Anteris Technologies Global on 10 of the 13 factors compared.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
